Process Systems Engineering for Pharmaceutical Manufacturing: From Product Design to Enterprise-Wide Decisions, Volume 41, covers the following process systems engineering methods and tools for the modernization of the pharmaceutical industry: computer-aided pharmaceutical product design and pharmaceutical production processes design/synthesis; modeling and simulation of the pharmaceutical processing unit operation, integrated flowsheets and applications for design, analysis, risk assessment, sensitivity analysis, optimization, design space identification and control system design; optimal operation, control and monitoring of pharmaceutical production processes; enterprise-wide optimization and supply chain management for pharmaceutical manufacturing processes. Currently, pharmaceutical companies are going through a paradigm shift, from traditional manufacturing mode to modernized mode, built on cutting edge technology and computer-aided methods and tools. Such shifts can benefit tremendously from the application of methods and tools of process systems engineering.

Carbon nanotubes suggested by scientist, have shown promising behavior to act as drug delivery tool as revealed from the present study. Due to greater storage capability of MWCNTs, they were used for the experiments instead of SWCNTs. Plenty of availability CVD prepared MWCNTs was one of the reason behind using them in the experiments. The drug characterization study was designed with at least two objectives in mind. Firstly, comparison of certain experimentally determined properties of the drug with those reported in Pharmacopoeia would authenticate the drug received as gift sample. Secondly, these preliminary studies of the drug properties would help further during more detailed experimental workup. Present study was planned to unravel the potential of CNTs as efficient controlled drug delivery vehicles and the results indicates the prospects of using CNTs as biomedical tools. These findings pave the way for further enhancing the properties of CNTs in terms of storage capacity, targeting potential and improving pharmacokinetics profile of drugs and biomolecules etc.